Kahl-McDonagh MM - Search Results

1

Polymeric particles in vaccine delivery.

Rice-Ficht AC, Arenas-Gamboa AM, Kahl-McDonagh MM, Ficht TA. Rice-Ficht AC, et al. Among authors: kahl mcdonagh mm. Curr Opin Microbiol. 2010 Feb;13(1):106-12. doi: 10.1016/j.mib.2009.12.001. Epub 2010 Jan 14. Curr Opin Microbiol. 2010. PMID: 20079678 Review.

2

Oral vaccination with microencapsuled strain 19 vaccine confers enhanced protection against Brucella abortus strain 2308 challenge in red deer (Cervus elaphus elaphus).

Arenas-Gamboa AM, Ficht TA, Davis DS, Elzer PH, Kahl-McDonagh M, Wong-Gonzalez A, Rice-Ficht AC. Arenas-Gamboa AM, et al. J Wildl Dis. 2009 Oct;45(4):1021-9. doi: 10.7589/0090-3558-45.4.1021. J Wildl Dis. 2009. PMID: 19901378

3

Evaluation of protection afforded by Brucella abortus and Brucella melitensis unmarked deletion mutants exhibiting different rates of clearance in BALB/c mice.

Kahl-McDonagh MM, Ficht TA. Kahl-McDonagh MM, et al. Infect Immun. 2006 Jul;74(7):4048-57. doi: 10.1128/IAI.01787-05. Infect Immun. 2006. PMID: 16790778 Free PMC article.

4

Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.

Kahl-McDonagh MM, Arenas-Gamboa AM, Ficht TA. Kahl-McDonagh MM, et al. Infect Immun. 2007 Oct;75(10):4923-32. doi: 10.1128/IAI.00451-07. Epub 2007 Jul 30. Infect Immun. 2007. PMID: 17664263 Free PMC article.

5

The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle.

Arenas-Gamboa AM, Ficht TA, Kahl-McDonagh MM, Gomez G, Rice-Ficht AC. Arenas-Gamboa AM, et al. Among authors: kahl mcdonagh mm. Infect Immun. 2009 Feb;77(2):877-84. doi: 10.1128/IAI.01017-08. Epub 2008 Dec 1. Infect Immun. 2009. PMID: 19047401 Free PMC article.

6

Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice.

Arenas-Gamboa AM, Rice-Ficht AC, Kahl-McDonagh MM, Ficht TA. Arenas-Gamboa AM, et al. Among authors: kahl mcdonagh mm. Infect Immun. 2011 Sep;79(9):3653-8. doi: 10.1128/IAI.05330-11. Epub 2011 Jun 27. Infect Immun. 2011. PMID: 21708998 Free PMC article.

7

Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16 M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-/- mouse model.

Arenas-Gamboa AM, Rice-Ficht AC, Fan Y, Kahl-McDonagh MM, Ficht TA. Arenas-Gamboa AM, et al. Among authors: kahl mcdonagh mm. Clin Vaccine Immunol. 2012 Feb;19(2):249-60. doi: 10.1128/CVI.05321-11. Epub 2011 Dec 14. Clin Vaccine Immunol. 2012. PMID: 22169089 Free PMC article.

8

Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge.

Arenas-Gamboa AM, Ficht TA, Kahl-McDonagh MM, Rice-Ficht AC. Arenas-Gamboa AM, et al. Among authors: kahl mcdonagh mm. Infect Immun. 2008 Jun;76(6):2448-55. doi: 10.1128/IAI.00767-07. Epub 2008 Mar 24. Infect Immun. 2008. PMID: 18362129 Free PMC article.

9

Brucellosis: the case for live, attenuated vaccines.

Ficht TA, Kahl-McDonagh MM, Arenas-Gamboa AM, Rice-Ficht AC. Ficht TA, et al. Among authors: kahl mcdonagh mm. Vaccine. 2009 Nov 5;27 Suppl 4(Suppl 4):D40-3. doi: 10.1016/j.vaccine.2009.08.058. Vaccine. 2009. PMID: 19837284 Free PMC article. Review.

10

Cytotoxicity in macrophages infected with rough Brucella mutants is type IV secretion system dependent.

Pei J, Wu Q, Kahl-McDonagh M, Ficht TA. Pei J, et al. Infect Immun. 2008 Jan;76(1):30-7. doi: 10.1128/IAI.00379-07. Epub 2007 Oct 15. Infect Immun. 2008. PMID: 17938217 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters